541 related articles for article (PubMed ID: 18199910)
1. Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms.
Zacharatou Jarlskog C; Lee C; Bolch WE; Xu XG; Paganetti H
Phys Med Biol; 2008 Feb; 53(3):693-717. PubMed ID: 18199910
[TBL] [Abstract][Full Text] [Related]
2. Comparison of whole-body phantom designs to estimate organ equivalent neutron doses for secondary cancer risk assessment in proton therapy.
Moteabbed M; Geyer A; Drenkhahn R; Bolch WE; Paganetti H
Phys Med Biol; 2012 Jan; 57(2):499-515. PubMed ID: 22217682
[TBL] [Abstract][Full Text] [Related]
3. Secondary neutron doses received by paediatric patients during intracranial proton therapy treatments.
Sayah R; Farah J; Donadille L; Hérault J; Delacroix S; De Marzi L; De Oliveira A; Vabre I; Stichelbaut F; Lee C; Bolch WE; Clairand I
J Radiol Prot; 2014 Jun; 34(2):279-96. PubMed ID: 24704989
[TBL] [Abstract][Full Text] [Related]
4. Neutron equivalent doses and associated lifetime cancer incidence risks for head & neck and spinal proton therapy.
Athar BS; Paganetti H
Phys Med Biol; 2009 Aug; 54(16):4907-26. PubMed ID: 19641238
[TBL] [Abstract][Full Text] [Related]
5. Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patients.
Athar BS; Bednarz B; Seco J; Hancox C; Paganetti H
Phys Med Biol; 2010 May; 55(10):2879-91. PubMed ID: 20427856
[TBL] [Abstract][Full Text] [Related]
6. Study of the secondary neutral radiation in proton therapy: toward an indirect in vivo dosimetry.
Carnicer A; Letellier V; Rucka G; Angellier G; Sauerwein W; Herault J
Med Phys; 2012 Dec; 39(12):7303-16. PubMed ID: 23231280
[TBL] [Abstract][Full Text] [Related]
7. Whole-body dose equivalent including neutrons is similar for 6 MV and 15 MV IMRT, VMAT, and 3D conformal radiotherapy.
Hauri P; Schneider U
J Appl Clin Med Phys; 2019 Mar; 20(3):56-70. PubMed ID: 30791198
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
Titt U; Zheng Y; Vassiliev ON; Newhauser WD
Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
[TBL] [Abstract][Full Text] [Related]
9. Neutron dosimetry in organs of an adult human phantom using linacs with multileaf collimator in radiotherapy treatments.
Martinez-Ovalle SA; Barquero R; Gomez-Ros JM; Lallena AM
Med Phys; 2012 May; 39(5):2854-66. PubMed ID: 22559658
[TBL] [Abstract][Full Text] [Related]
10. Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age.
Zacharatou Jarlskog C; Paganetti H
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):228-35. PubMed ID: 18571337
[TBL] [Abstract][Full Text] [Related]
11. Monte Carlo study of neutron dose equivalent during passive scattering proton therapy.
Zheng Y; Newhauser W; Fontenot J; Taddei P; Mohan R
Phys Med Biol; 2007 Aug; 52(15):4481-96. PubMed ID: 17634645
[TBL] [Abstract][Full Text] [Related]
12. Measurements of the neutron dose equivalent for various radiation qualities, treatment machines and delivery techniques in radiation therapy.
Hälg RA; Besserer J; Boschung M; Mayer S; Lomax AJ; Schneider U
Phys Med Biol; 2014 May; 59(10):2457-68. PubMed ID: 24778349
[TBL] [Abstract][Full Text] [Related]
13. Influence of beam incidence and irradiation parameters on stray neutron doses to healthy organs of pediatric patients treated for an intracranial tumor with passive scattering proton therapy.
Bonfrate A; Farah J; De Marzi L; Delacroix S; Hérault J; Sayah R; Lee C; Bolch WE; Clairand I
Phys Med; 2016 Apr; 32(4):590-9. PubMed ID: 27050170
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of different dose scoring methods on organ-specific neutron dose calculations in proton therapy.
Jarlskog CZ; Paganetti H
Phys Med Biol; 2008 Sep; 53(17):4523-32. PubMed ID: 18677040
[TBL] [Abstract][Full Text] [Related]
15. Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment.
Jiang H; Wang B; Xu XG; Suit HD; Paganetti H
Phys Med Biol; 2005 Sep; 50(18):4337-53. PubMed ID: 16148397
[TBL] [Abstract][Full Text] [Related]
16. Monte Carlo simulations of neutron spectral fluence, radiation weighting factor and ambient dose equivalent for a passively scattered proton therapy unit.
Zheng Y; Fontenot J; Taddei P; Mirkovic D; Newhauser W
Phys Med Biol; 2008 Jan; 53(1):187-201. PubMed ID: 18182696
[TBL] [Abstract][Full Text] [Related]
17. Out-of-field contributions for IMRT and volumetric modulated arc therapy measured using gafchromic films and compared to calculations using a superposition/convolution based treatment planning system.
Van den Heuvel F; Defraene G; Crijns W; Bogaerts R
Radiother Oncol; 2012 Oct; 105(1):127-32. PubMed ID: 22300610
[TBL] [Abstract][Full Text] [Related]
18. Validation of a Monte Carlo Framework for Out-of-Field Dose Calculations in Proton Therapy.
De Saint-Hubert M; Verbeek N; Bäumer C; Esser J; Wulff J; Nabha R; Van Hoey O; Dabin J; Stuckmann F; Vasi F; Radonic S; Boissonnat G; Schneider U; Rodriguez M; Timmermann B; Thierry-Chef I; Brualla L
Front Oncol; 2022; 12():882489. PubMed ID: 35756661
[TBL] [Abstract][Full Text] [Related]
19. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
[TBL] [Abstract][Full Text] [Related]
20. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT.
Reft CS; Runkel-Muller R; Myrianthopoulos L
Med Phys; 2006 Oct; 33(10):3734-42. PubMed ID: 17089839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
